Evidence map›Paper›PMID 34878308›Full record

ArticleMicrobiology spectrum2021

Emerging Opportunity and Destiny of

Xiaoyu Lu, Xia Xiao, Yuan Liu, Ruichao Li, Zhiqiang Wang

Abstract read
In one paragraph

Article in Microbiology spectrum, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Virulence · 2026
    Review
  2. Review
  3. Review
  4. One Health at Risk: Plasmid-Mediated Spread ofAntibiotics (Basel, Switzerland) · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Mobile Colistin Resistance (Antibiotics (Basel, Switzerland) · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Increased Expression and Amplification ofMicrobiology spectrum · 2022
    Article
  14. International Spread of Tet(X4)-ProducingFoods (Basel, Switzerland) · 2022
    Article
  15. Coexistence ofMicrobiology spectrum · 2022
    Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiaoyu LuJiangsu CoInnovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou Universitygrid.268415.c, Yangzhou, Jiangsu Province, People's Republic of China.ORCID 0000-0002-1330-5925
Xia XiaoJiangsu CoInnovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou Universitygrid.268415.c, Yangzhou, Jiangsu Province, People's Republic of China.
Yuan LiuJiangsu CoInnovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou Universitygrid.268415.c, Yangzhou, Jiangsu Province, People's Republic of China.ORCID 0000-0002-9622-6471
Ruichao LiJiangsu CoInnovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou Universitygrid.268415.c, Yangzhou, Jiangsu Province, People's Republic of China.ORCID 0000-0001-8333-9891
Zhiqiang WangJiangsu CoInnovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou Universitygrid.268415.c, Yangzhou, Jiangsu Province, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of the plasmid-mediated colistin resistance gene

Indexed as

PlasmidsAnti-Bacterial AgentsColistinDrug Resistance, Multiple, BacterialEscherichia coliEscherichia coli InfectionsEscherichia coli ProteinsGenes, BacterialHumansMicrobial Sensitivity TestsTigecyclineAnti-Bacterial AgentsColistinEscherichia coli ProteinsMCR-1 protein, E coliTigecyclineEscherichia colifitness costsfusion plasmidsmcr-1plasmid evolutiontet(X4)

Identifiers

PMID34878308
PMCPMC8653826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.